L01XE Protein kinase inhibitors

No definition available.

Endpoint definition

↥
FinnGen phenotype data
diagram bullet diagram downward connector

Filter registries KELA purch., KELA reimb.

Medicine purchases: ATC L01XE
Medicine purchases: ATC: other data required >3 instances required

Check pre-conditions None

Include endpoints None

Check conditions None

Apply sex-specific rule None

diagram downward connector RX_L01XE

Extra metadata

First used in FinnGen datafreeze DF3

Summary Statistics

↥

Key figures

All Female Male
Number of individuals 1041 528 513
Unadjusted prevalence (%) 0.40 0.36 0.45
Mean age at first event (years) 65.32 63.61 67.08

Mortality

Follow-up Absolute risk HR [95% CI] p N
1998–2019 - - - -
15 years - - - -
5 years - - - -
1 year - - - -

Correlations

↥

Index endpoint: RX_L01XE – L01XE Protein kinase inhibitors
GWS hits:

Survival analyses between endpoints

↥

Plot

before L01XE Protein kinase inhibitors
after L01XE Protein kinase inhibitors

loading spinner Loading survival analyses plot

Drugs most likely to be purchased after L01XE Protein kinase inhibitors

↥